murine MAb against human PAI-1, clone HD-PAI-1 14.1
Description
The monoclonal antibody ADG3786 (clone HD-PAI-1 14.1) is a murine monoclonal antibody, subclass IgG1 recognizing the human Plasminogen Activator Inhibitor Type 1 (PAI-1). Mice were immunized with purified recombinant PAI-1, expressed in a prokaryotic expression system. The antibody has been purified from cell culture supernatant using Protein A affinity chromatography. The antibody reacts with both native and recombinant PAI-1
Presentation
Screw capped vial containing 250 µg of purified antibody in PBS pH 7.4 + 0.01% ProClin300. The IgG concentration is 1 mg/ml. Spin the vial briefly before opening.
Storage and Stability
Store the antibody at 2°-8°C. For long-term storage the antibody should be aliquoted and stored at –20°C or colder. It is recommended to avoid freeze-thaw cycles.
Specificity
The antibody recognizes both active and inactive forms of PAl-1, and in addition it recognizes PAI-1 complexed with urokinase, tissue-type plasminogen activators, or vitronectin. (1, 2)
The antibody is specific for human PAI-1, no cross-reactivity was observed against other members of the plasminogen activator system (PAI-2, uPA, or tPA).
Applications
ELISA
The antibody can be used as capture or detection antibody in ELISAs. (1, 2)
Western Blot
The antibody is suitable for immuno-blotting. It recognizes native (a) and recombinant (b) human PAI-1.
Immunohistochemistry
The antibody can be used for immunohistological staining of formalin-fixed, paraffin-embedded tissue sections.
Category: Research use only
Type: Antibody
Product Availability: Worldwide
Manufacturer: ImmBioMed GmbH & Co KG, Germany
For more information please click .pdf icon below.
murine MAb against human PAI-1, clone HD-PAI-1 14.1
Cat.No. ADG3786
Article no.: 938499
Unit: 250 µg
Code: ADG3786
Manufacturer: ImmBioMed GmbH & Co. KG
References
- Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. Foekens JA et al., J Clin Oncol. 1994 Aug;12(8):1648-58.
- Enzyme-linked immunosorbent assay for plasminogen activator inhibitor-I (PAl-1), Kramer MD, el al., in Schmitt M, Graeff H, Kindermann G (eds): Prospects in Diagnosis and Treatment of Breast Cancer. Excerpta Medica International Congress Series. New York, NY, Elsevier, 1994, pp 187-196.